Jocelyn Carver
Primary Care · Littleton, CONPI 1144730326
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 125 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by AbbVie at 31.4% of the total. Reporting peaked in 2023 at $654 and has fallen 68.7% since, to $205 in 2025. Among primary care clinicians in CO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 125 payments — averaging $16.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$653
- Lilly USA, LLC$319
- Novo Nordisk$254
- AstraZeneca$154
- Amgen$131
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$82
- plus $489 from 15 others
What the payments were for
- Food & beverage$2,082100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 40 | $653 |
| Lilly USA, LLC | 20 | $319 |
| Novo Nordisk | 12 | $254 |
| AstraZeneca | 11 | $154 |
| Amgen | 8 | $131 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $82 |
| Pfizer | 4 | $77 |
| Biohaven Pharmaceuticals, Inc. | 4 | $72 |
| GSK | 4 | $66 |
| Impel Pharmaceuticals Inc. | 3 | $53 |
| Idorsia Pharmaceuticals US Inc | 3 | $44 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $28 |
| Upsher-smith Laboratories LLC | 1 | $20 |
| Axsome Therapeutics, Inc. | 1 | $20 |
| Antares Pharma, Inc. | 1 | $17 |
| Eisai Inc. | 1 | $16 |
| Genentech USA, Inc. | 1 | $16 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $15 |
| Mylan Specialty L.p. | 1 | $15 |
| Merck | 1 | $15 |
| Astellas Pharma US Inc | 1 | $13 |
How this compares
$2,082 in reported general payments places this provider in the 90th percentile of 112 primary care providers in Colorado.
Other primary care in Littleton
- Laura CarlsenLittleton$22K
- Katharine GellishLittleton$263
- Rachel DeitsLittleton$186
- Kendra PayneCastle Rock$22K
- Kaitlin KrausDenver$16K
- Emily WillmannThornton$4K
- Tracy RasmussenParker$4K
- Linda MyersGrand Junction$4K
- Kathryn PalmerGreeley$4K
- Leah BrownFort Morgan$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.